FDA Investigator Jeffrey J Ebersole
Jeffrey J Ebersole has inspections in 1 countries as of 11 Jul 2023. Jeffrey J Ebersole has collaborated with a combined 1312 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
26
Last Inspection Date:
11 Jul 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Addam S Reynolds,
Alberto A Viciedo,
Allen Lou,
Amy L Singer,
Amy M Cramer,
Ana S Cabrera,
Annemarie B Randow,
Annemarie Bodnar,
Anthony M Criscuolo, Jr,
Barbara J Maulfair,
Barbara Jwilimczyk Macri,
Cary Greene,
Charles J Chacko,
Chiang Syin, PhD,
Christina N Maurino,
Daniel J Grabicki,
Devon Jenkins,
Douglas C Kovacs,
Dr. Sriram Subramaniam, PhD,
Edward D Mcdonald,
Emest F Bizjak,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Frederick Razzaghi,
Gayle S Lawson,
Gianine E Delade,
Gianine E Tompkins,
Helen B Ricalde,
Helen Verdel,
Herrmann,
Jason M Sluzynski,
Jeffrey J, Ebersole,
Joy Rkozlowski Klena,
Juanita P Versace,
Karen E D'orazio,
Keith M Reilley,
Keith M Reilly,
Kelli F Dobilas,
Kerry A Kurdilla,
King,
Kristina J Donohue,
Kristy A Zielny,
Laishan L Lam,
Lawrence R Johnson,
Li Li,
Lisa B Hall,
Margaret M Sands,
Marie T Falcone,
Marjorie D Schultz,
Melissa B Libby,
Merril E Racke,
Michael R Klapal,
Nancy L Rolli,
Nerizza B Guerin,
Nicholas A Violand,
Paul L Bellamy,
Philip F Istafanos, DMV, MS,
Regina T Brown,
Remache,
Richard H Penta,
Robert G Ruff,
Robert Sharpnack,
Rochelle K Kimmel,
Sarah Forney,
Schultz,
Sherri J Liu,
Sinai Davis,
State Agency,
Susan M Halsted,
Tania E Garcia,
Tania E Vizcaino,
Tara G Bizjak,
Tara R Gooen,
Toyin B Oladimeji,
Valerie C Reed,
Willy A Orantes
Jeffrey J Ebersole's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2001 | EIR | Kenwood Therapeutics - EIR, 2001-04-10 |
November, 2000 | FDA 483 Response | Novus Fine Chemicals - Form 483R, 2000-12-01 |
November, 2001 | EIR | Frutarom USA Inc. - EIR, 2001-11-08 |
November, 2000 | EIR | Novus Fine Chemicals - EIR, 2000-11-27 |
July, 2001 | FDA 483 Response | The P.F. Laboratories Inc. - Form 483R, 2001-08-02 |
November, 2000 | FDA 483 | Novus Fine Chemicals - Form 483, 2000-11-27 |
August, 2001 | EIR | McNeil PPC Inc. - EIR, 2001-08-22 |
October, 2001 | FDA 483 Response | Watson Pharma, Inc. - Form 483R, 2001-12-03 |
July, 2001 | EIR | The P.F. Laboratories Inc. - EIR, 2001-07-06 |
November, 2001 | FDA 483 | Frutarom USA Inc. - Form 483, 2001-11-08 |
March, 2002 | FDA 483 | Sonar Products, Inc. - Form 483, 2002-01-02 |
July, 2001 | FDA 483 | Sonar Products, Inc. - Form 483, 2001-07-31 |
October, 2001 | FDA 483 | Watson Pharma, Inc. - Form 483, 2001-10-30 |
July, 2001 | FDA 483 | The P.F. Laboratories Inc. - Form 483, 2001-07-06 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more